Sagimet Biosciences (SGMT) analyst forecast and price target
Analyst forecast
Consensus of 12 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $29.00 | Aug 25, 2026 |
| Citizens | Maintained | Market Outperform | $29.00 from $12.00 | Aug 14, 2026 |
| Canaccord Genuity | Maintained | Buy | $56.00 from $49.00 | Aug 12, 2026 |
| Citizens | Maintained | Market Outperform | $12.00 from $35.00 | May 19, 2026 |
| Canaccord Genuity | Maintained | Buy | $49.00 from $28.00 | May 4, 2026 |
| Guggenheim | Maintained | Buy | $25.00 from $27.00 | Apr 29, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $29.00 | Mar 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $29.00 | Feb 3, 2026 |
| Guggenheim | Initiated Coverage | Buy | $27.00 | Feb 3, 2026 |
| Barclays | Initiated Coverage | Equal-Weight | $8.00 | Jan 28, 2026 |
| Citizens | Maintained | Market Outperform | $35.00 from $33.00 | Nov 14, 2025 |
| Clear Street | Initiated Coverage | Buy | $29.00 | Oct 22, 2025 |
| Canaccord Genuity | Maintained | Buy | $28.00 | Oct 2, 2025 |
| Wedbush | Initiated Coverage | Outperform | $28.00 | Aug 11, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $29.00 | Aug 7, 2025 |
| Canaccord Genuity | Initiated Coverage | Buy | $28.00 | Jul 24, 2025 |
| Jones Trading | Maintained | Buy | $27.00 from $15.00 | Jun 6, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $32.00 | Mar 13, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $32.00 | Mar 11, 2025 |
| Jones Trading | Initiated Coverage | Buy | $42.00 | Jan 27, 2025 |
Frequently asked questions
What is the price target for SGMT stock?
The average 12-month analyst price target for Sagimet Biosciences (SGMT) is $38.00, with a high estimate of $56.00 and a low of $29.00, across 3 analysts.
Is SGMT a buy, sell, or hold?
Analysts covering Sagimet Biosciences currently average a Buy rating: 11 buy, 1 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for SGMT?
The average price target of $38.00 implies 270.37% upside from the last price of $10.26.
What is the latest analyst rating on SGMT?
On Aug 25, 2026, HC Wainwright & Co. maintained Sagimet Biosciences at Buy with a price target of $29.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.